These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 8117838)

  • 21. The importance of the light chain for the epitope specificity of human anti-U1 small nuclear RNA autoantibodies present in systemic lupus erythematosus patients.
    Hoet RM; Pieffers M; Stassen MH; Raats J; de Wildt R; Pruijn GJ; van den Hoogen F; van Venrooij WJ
    J Immunol; 1999 Sep; 163(6):3304-12. PubMed ID: 10477600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes.
    Gorgani NN; Parish CR; Easterbrook Smith SB; Altin JG
    Biochemistry; 1997 Jun; 36(22):6653-62. PubMed ID: 9184145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of human C1q with IgG and IgM: revisited.
    Gadjeva MG; Rouseva MM; Zlatarova AS; Reid KB; Kishore U; Kojouharova MS
    Biochemistry; 2008 Dec; 47(49):13093-102. PubMed ID: 19006321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a light chain product of the human JC lambda 7 gene complex.
    Niewold TA; Murphy CL; Weiss DT; Solomon A
    J Immunol; 1996 Nov; 157(10):4474-7. PubMed ID: 8906824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of amyloidogenic immunoglobulin light chains directly from serum by on-line immunoaffinity isolation.
    Bergen HR; Abraham RS; Johnson KL; Bradwell AR; Naylor S
    Biomed Chromatogr; 2004 Apr; 18(3):191-201. PubMed ID: 15103706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exposure of thyroxine residues in human thyroglobulin. Two-site binding studies.
    Byfield PG; Clingan D; Himsworth RL
    Biochem J; 1984 Apr; 219(2):405-10. PubMed ID: 6743226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cytophilic activity of human immunoglobulins.
    Inchley C; Grey HM; Uhr JW
    J Immunol; 1970 Aug; 105(2):362-9. PubMed ID: 4915774
    [No Abstract]   [Full Text] [Related]  

  • 28. [Interaction of radiographic contrast media with immunoglobulins].
    Bauer K
    Rofo; 1983 Feb; 138(2):190-6. PubMed ID: 6402428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of binding of thyroxin-conjugates to the thyroxin-binding proteins.
    Georgiou S; Christofidis I
    J Immunoassay; 1996 Feb; 17(1):47-66. PubMed ID: 8926306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating thyroid hormones in a patient with hyperviscosity syndrome.
    Tamagna E; Hershman J; Premachandra BN
    Clin Chim Acta; 1979 Apr; 93(2):263-8. PubMed ID: 445846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thea value and limits to kinetic analysis of human serum Ig. Preliminary note].
    Biagi R; Rovinetti C; Nubile G
    Boll Soc Ital Biol Sper; 1979 May; 55(9):833-9. PubMed ID: 553607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunoglobulins, paraproteins and hemoglobin-binding proteins in their significance for clinical practice].
    Braun HJ
    Dtsch Med J; 1972 Mar; 23(3):227-33. PubMed ID: 5036533
    [No Abstract]   [Full Text] [Related]  

  • 33. Kinetic and thermodynamic studies of antigen-antibody interactions in heterogeneous reaction phases--I. L-thyroxine (T4) with specific antibody immobilized on controlled pore glass.
    Hertl W; Odstrchel G
    Mol Immunol; 1979 Mar; 16(3):173-8. PubMed ID: 489052
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum proteins in normal and pathological conditions: The blood serum of normal animals. II. Human blood serum and pathological body fluids. III. Horse serum studied by means of the precipitin reaction.
    Hewitt LF
    Biochem J; 1938 Sep; 32(9):1540-53. PubMed ID: 16746782
    [No Abstract]   [Full Text] [Related]  

  • 35. [Interaction of thyroid hormones with immunoglobulins isolated from human blood serum. I. Parameters of complex formation and the nature of the binding reaction].
    Sviridov OV; Ermolenko MN
    Biokhimiia; 1994 Jan; 59(1):78-87. PubMed ID: 8117838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interaction of thyroid hormones with immunoglobulins isolated from human blood serum. II. Structural elements and localization of thyroxine-binding segment in the immunoglobulin M molecule].
    Ermolenko MN; Sviridov OV
    Biokhimiia; 1994 Jan; 59(1):88-95. PubMed ID: 8117839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Simulating and inhibiting effect of individual blood serum transport proteins on thyroid hormone binding with human placental cell membrane].
    Karpyza EI; Kiklevich IE; Ermolenko MN; Sviridov OV
    Biokhimiia; 1993 Feb; 58(2):285-94. PubMed ID: 8485219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
    Harris DL; King E; Ramsland PA; Edmundson AB
    J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A new property of known proteins: specific binding of thyroid hormones by human plasma apolipoproteins].
    Sviridov OV
    Biokhimiia; 1994 May; 59(5):625-38. PubMed ID: 8043689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered protein scaffolds for molecular recognition.
    Skerra A
    J Mol Recognit; 2000; 13(4):167-87. PubMed ID: 10931555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.